Arcellx (ACLX) Total Current Liabilities (2021 - 2025)

Arcellx's (ACLX) quarterly Total Current Liabilities came in at $104.2 million in Q4 2025, down 16.91% year-on-year from $125.4 million in Q4 2024, and down 11.99% quarter-over-quarter from $118.4 million in Q3 2025.

Arcellx (ACLX) Total Current Liabilities (2021 - 2025) Analysis & Trends

Arcellx's Total Current Liabilities history runs 5 years deep, the most recent figure standing at $104.2 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 16.91% year-over-year to $104.2 million in Q4 2025; TTM through Dec 2025 was $104.2 million, a 16.91% decrease from a year earlier, with the FY2025 full-year figure at $104.2 million, down 16.91% from the prior year.
  • Total Current Liabilities eased to $104.2 million in Q4 2025 per ACLX's latest filing, from $118.4 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $173.1 million in Q3 2023 and bottomed at $14.4 million in Q1 2022.
  • The 5-year median for Total Current Liabilities is $112.5 million (2025), against an average of $99.0 million.
  • Across the five-year window, Total Current Liabilities jumped 1051.18% in 2023 and plunged 43.45% in 2024, its largest moves.
  • Year by year, Total Current Liabilities stood at $14.8 million in 2021, then surged by 281.9% to $56.7 million in 2022, then soared by 108.56% to $118.2 million in 2023, then climbed by 6.06% to $125.4 million in 2024, then decreased by 16.91% to $104.2 million in 2025.
  • Per Business Quant, the three latest ACLX Total Current Liabilities figures stand at $104.2 million (Q4 2025), $118.4 million (Q3 2025), and $121.8 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 104.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 104.20 Mn
Sep 30, 2025 118.39 Mn
Jun 30, 2025 121.85 Mn
Mar 31, 2025 112.46 Mn
Dec 31, 2024 125.41 Mn
Sep 30, 2024 137.02 Mn
Jun 30, 2024 88.29 Mn
Mar 31, 2024 107.90 Mn
Dec 31, 2023 118.24 Mn
Sep 30, 2023 173.15 Mn
Jun 30, 2023 156.11 Mn
Mar 31, 2023 166.06 Mn
Dec 31, 2022 56.69 Mn
Sep 30, 2022 44.78 Mn
Jun 30, 2022 23.73 Mn
Mar 31, 2022 14.43 Mn
Dec 31, 2021 14.85 Mn